New Horizons in The Treatment of Pulmonary Fibrosis

Evening Symposium
Chairs: A. Wells London (United Kingdom)
Aims: Organised by Boehringer Ingelheim International GmbH

Welcome and introduction A. Wells (London, United Kingdom)
The pathogenesis of IPF: what is the latest paradigm? P. Sime (Rochester, United States of America)
Splitting: the road to precision medicine in IPF? E. White (Ann Arbor, United States of America)
Questions and answers No content made available	No content made available
Lumping: are the commonalities among fibrosing ILDs more important than the differences? V. Cottin (Lyon, France)
How should we approach the treatment of progressive fibrosing ILDs? K. Brown (Denver, United States of America)
SSc-ILD: are we entering a new chapter in treatment? T. Maher (St. Albans, United Kingdom)
Questions and answers No content made available	No content made available
Summary and close A. Wells (London, United Kingdom) No content made available	No content made available